Searchable abstracts of presentations at key conferences in endocrinology

ea0033p83 | (1) | BSPED2013

BSPED National thyrotoxicosis study: patient characteristics and initial response to antithyroid drug therapy

Balasubrahmanyam Vani , Davidson Neil , Harle Christine , Cheetham on behalf of BSPED Tim

Introduction: The BSPED UK thyrotoxicosis study has been running for 10 years. The primary objective is to assess biochemical control on block and replace (BR) and dose titration (DT) regimens. The final patient was recruited towards the end of 2011 and study will finish in 2015. We would like to describe the baseline characteristics of study patients and the initial response to anti-thyroid drug therapy (ATD).Methods: We focused on patient age, sex, BMI...

ea0074ncc48 | Highlighted Cases | SFENCC2021

The pragmatic use of corticosteroids in the diagnosis and treatment of non-PTH driven hypercalcaemia

Yousif Yasear Zainab Akram , Ijaz Nadia , Gittoes Neil , Sanders Anna , Pang Terence

A 65-year-old gentleman was referred by his GP because of acute kidney injury and hypercalcaemia, which was associated with low levels of parathyroid hormone. He had been fit and well and was on no regular medications. Whilst his hypercalcaemia was partly correctible with saline rehydration, cautious use of bisphosphonates and cinacalcet were not effective in preventing rebound, and his nephropathy persisted. Curiously, he had longstanding low plasma alkaline phosphatase, but had normal denti...

ea0065p339 | Nursing practice | SFEBES2019

Use of a holistic needs assessment questionnaire to inform ‘late effects’ clinic appointments for childhood cancer survivors

McGoldrick Sophie , Crown Anna , Davidson Anne

The number of childhood cancer survivors is ever increasing and as this population continues to grow, the long term physical and psychological impact of having cancer treatment in childhood becomes ever more apparent. Childhood cancer survivors are moving into adulthood with significant health needs secondary to their cancer treatment. Acknowledging and addressing these needs is crucial in supporting them on their continued health journey. Patients attending the ‘late eff...

ea0007p85 | Endocrine tumours and neoplasia | BES2004

Urinary free metadrenalines provide the best diagnostic biochemical test for phaeochromocytoma; experience in a tertiary care centre

Boyle J , Davidson D , Connell J

Background: Recommendations for the diagnosis of phaeochromocytoma are based on individual institutional experience but have traditionally advocated concurrent measurement of urine and plasma catecholamines. However, reports of phaeochromocytoma presenting with normal catecholamines suggest that this practice is insufficiently sensitive. In phaeochromocytoma there is an increased output of metadrenaline metabolites with a disproprtionate increase in the unconjugated form and e...

ea0077ecs1.3 | Broadening your Career Pathway - What else can you do with your skills? | SFEBES2021

Influencing at scale: NHS leadership and shaping policy

Gittoes Neil

Clinical interactions with patients are fulfilling and rewarding. We can make a difference to patients’ health and lives by tuning care and attention to their individual needs on a 1:1 basis. Frustrations sometimes emerge from clinicians due to perceived restrictions and limitations in the healthcare system that appear to perversely impact patient care. Those frustrations are often exacerba...

ea0051cme7 | CME Training Day Abstracts | BSPED2017

Insulin pumps and CGMS – what’s new?

Wright Neil

Continuous Glucose Monitoring and Flash Glucose Sensing are exciting new technologies popular with many patients and their parents who are keen to have access to such technologies. However such technologies are costly and it is important that clinicians identify patients who are most likely to benefit and ensure that families have appropriate training in order to optimise their use. The aims of this overview are firstly to review the evidence underpinning CGMS and to discuss t...

ea0081s4.1 | Parathyroid disorders clinical update (PARAT group) | ECE2022

Management of primary hyperparathyroidism (PHPT)

Gittoes Neil

The European PARAT group have recently explored a number of practical management issues in parathyroid diseases. Herein, we present expert opinion on areas of controversy in the diagnosis and management of primary hyperparathyroidism (PHPT). Although PHPT is common, its differential diagnosis from familial hypocalciuric hypercalcaemia (FHH) poses practical problems. Proposed approaches to addressing this will be discussed. The definition and clinical course of normocalcemic PH...

ea0065cmw2.3 | Hyperparathyroidism | SFEBES2019

Challenges in recurrent hyperparathyroidism

Gittoes Neil

Success following initial parathyroid surgery is high at approximately 95%. Developments in preoperative imaging techniques and subtle variations in parathyroid surgical approach have marginally improved already high success rates. However, failed initial neck exploration or true later recurrence of primary hyperparathyroidism (PHPT) can be difficult to manage. The initial consideration is always to ensure that the diagnosis of PHPT is secure and it is prudent to re-evaluate t...

ea0065ns2.2 | Management of Hyper and Hypocalcaemia | SFEBES2019

Patient management of hypercalcaemia and when should the surgeon intervene?

Gittoes Neil

Hypercalcaemia is common and can represent a broad spectrum of underlying diseases that range from common to extremely rare. Furthermore, causes of hypercalcaemia can be mild and indolent or may be rapidly progressive and represent serious underlying diseases such as cancers. It is thus important to have a clear understanding of hypercalcaemia, particularly its early assessment and management that will lead to a diagnosis of the underlying cause. Hypercalcaemia can present as ...

ea0038apw1.3 | Evolving model systems for complex tissues | SFEBES2015

Cell replacement and regeneration of β cells as novel therapy for diabetes

Hanley Neil

The last couple of years have seen an advance in generating human β-cells from pluripotent stem cells. It is now clear that cells of greatly increased maturity can be obtained from robust protocols. In addition to improving the prospects of cell replacement therapy, these developments allied to greater understanding of how human β-cells are first generated in the body are allowing development of more complex model systems. These model systems are likely to be importa...